Kate Therapeutics
Aislinn Puga has extensive experience in office management and executive assistance, with roles in various industries ranging from pharmaceuticals to telecommunications. Aislinn has managed large teams of employees, coordinated work assignments, and provided exceptional customer service. Aislinn also holds a degree in General Studies from Palomar College.
This person is not in any teams
Kate Therapeutics
Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.